B
Boston Health Economics
Develops innovative solutions for healthcare data analysis
About Boston Health Economics
BHE, founded by Joseph Menzin, Ph.D., in 1996, is a health analytics research firm specializing in health economics and outcomes research. The company operates primarily in the life sciences sector, serving clients such as pharmaceutical companies, healthcare providers, and research institutions. BHE offers a range of services including custom research projects and its flagship product, the Instant Health Data (IHD) platform. This SaaS-based platform provides real-world evidence (RWE) analytics, enabling organizations to accelerate their research and answer complex healthcare questions. BHE's business model revolves around subscription fees for its IHD platform and fees for custom research projects. The company generates revenue by providing high-quality, transparent analytics solutions that demonstrate value to its clients and support their decision-making processes.
Source: Dealroom company dataAt a glance
- Founded
- 1996
- Headquarters
- Waltham, United States
- Sector
- Health Tech & Medtech
Latest news
Press, funding announcements and product moves mentioning Boston Health Economics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Silversmith Capital Partners
Transformation Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Boston Health Economics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Boston Health Economics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.